vs

Side-by-side financial comparison of UPWORK, INC (UPWK) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

UPWORK, INC is the larger business by last-quarter revenue ($198.4M vs $127.1M, roughly 1.6× Zai Lab Ltd). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs 3.6%). UPWORK, INC produced more free cash flow last quarter ($63.2M vs $-26.7M). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 1.9%).

Upwork Inc. is an American freelancing platform headquartered in Santa Clara and San Francisco, California. The company was formed in 2013 as Elance-oDesk after the merger of Elance Inc. and oDesk Corp. The merged company was subsequently rebranded as Upwork in 2015.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

UPWK vs ZLAB — Head-to-Head

Bigger by revenue
UPWK
UPWK
1.6× larger
UPWK
$198.4M
$127.1M
ZLAB
Growing faster (revenue YoY)
ZLAB
ZLAB
+13.5% gap
ZLAB
17.1%
3.6%
UPWK
More free cash flow
UPWK
UPWK
$89.9M more FCF
UPWK
$63.2M
$-26.7M
ZLAB
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
1.9%
UPWK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
UPWK
UPWK
ZLAB
ZLAB
Revenue
$198.4M
$127.1M
Net Profit
$15.6M
Gross Margin
78.0%
51.0%
Operating Margin
14.3%
-54.6%
Net Margin
7.9%
Revenue YoY
3.6%
17.1%
Net Profit YoY
-89.4%
EPS (diluted)
$0.12
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
UPWK
UPWK
ZLAB
ZLAB
Q4 25
$198.4M
$127.1M
Q3 25
$201.7M
$115.4M
Q2 25
$194.9M
$109.1M
Q1 25
$192.7M
$105.7M
Q4 24
$191.5M
$108.5M
Q3 24
$193.8M
$101.8M
Q2 24
$193.1M
$100.1M
Q1 24
$190.9M
$87.1M
Net Profit
UPWK
UPWK
ZLAB
ZLAB
Q4 25
$15.6M
Q3 25
$29.3M
$-36.0M
Q2 25
$32.7M
$-40.7M
Q1 25
$37.7M
$-48.4M
Q4 24
$147.2M
Q3 24
$27.8M
$-41.7M
Q2 24
$22.2M
$-80.3M
Q1 24
$18.4M
$-53.5M
Gross Margin
UPWK
UPWK
ZLAB
ZLAB
Q4 25
78.0%
51.0%
Q3 25
77.3%
59.5%
Q2 25
77.7%
60.6%
Q1 25
78.3%
63.6%
Q4 24
77.7%
61.5%
Q3 24
77.6%
64.1%
Q2 24
77.3%
64.9%
Q1 24
76.9%
61.4%
Operating Margin
UPWK
UPWK
ZLAB
ZLAB
Q4 25
14.3%
-54.6%
Q3 25
14.8%
-42.3%
Q2 25
16.7%
-50.3%
Q1 25
20.1%
-53.3%
Q4 24
7.1%
-62.6%
Q3 24
10.7%
-66.6%
Q2 24
9.2%
-76.0%
Q1 24
6.8%
-80.7%
Net Margin
UPWK
UPWK
ZLAB
ZLAB
Q4 25
7.9%
Q3 25
14.5%
-31.2%
Q2 25
16.8%
-37.3%
Q1 25
19.6%
-45.8%
Q4 24
76.9%
Q3 24
14.3%
-40.9%
Q2 24
11.5%
-80.2%
Q1 24
9.7%
-61.4%
EPS (diluted)
UPWK
UPWK
ZLAB
ZLAB
Q4 25
$0.12
$-0.05
Q3 25
$0.21
$-0.03
Q2 25
$0.24
$-0.04
Q1 25
$0.27
$-0.04
Q4 24
$1.02
$-0.09
Q3 24
$0.20
$-0.04
Q2 24
$0.17
$-0.08
Q1 24
$0.13
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
UPWK
UPWK
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$672.8M
$689.6M
Total DebtLower is stronger
$359.8M
Stockholders' EquityBook value
$630.3M
$715.5M
Total Assets
$1.3B
$1.2B
Debt / EquityLower = less leverage
0.57×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
UPWK
UPWK
ZLAB
ZLAB
Q4 25
$672.8M
$689.6M
Q3 25
$643.1M
$717.2M
Q2 25
$634.6M
$732.2M
Q1 25
$622.1M
$757.3M
Q4 24
$622.1M
$779.7M
Q3 24
$601.2M
$616.1M
Q2 24
$497.7M
$630.0M
Q1 24
$490.6M
$650.8M
Total Debt
UPWK
UPWK
ZLAB
ZLAB
Q4 25
$359.8M
Q3 25
$359.3M
Q2 25
Q1 25
Q4 24
$357.9M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
UPWK
UPWK
ZLAB
ZLAB
Q4 25
$630.3M
$715.5M
Q3 25
$628.1M
$759.9M
Q2 25
$608.7M
$791.7M
Q1 25
$594.3M
$810.8M
Q4 24
$575.4M
$840.9M
Q3 24
$411.2M
$667.7M
Q2 24
$361.1M
$704.2M
Q1 24
$348.9M
$762.2M
Total Assets
UPWK
UPWK
ZLAB
ZLAB
Q4 25
$1.3B
$1.2B
Q3 25
$1.3B
$1.2B
Q2 25
$1.3B
$1.2B
Q1 25
$1.2B
$1.2B
Q4 24
$1.2B
$1.2B
Q3 24
$1.1B
$985.3M
Q2 24
$1.0B
$987.4M
Q1 24
$1.0B
$988.4M
Debt / Equity
UPWK
UPWK
ZLAB
ZLAB
Q4 25
0.57×
Q3 25
0.57×
Q2 25
Q1 25
Q4 24
0.62×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
UPWK
UPWK
ZLAB
ZLAB
Operating Cash FlowLast quarter
$63.7M
$-26.0M
Free Cash FlowOCF − Capex
$63.2M
$-26.7M
FCF MarginFCF / Revenue
31.9%
-21.0%
Capex IntensityCapex / Revenue
0.2%
0.5%
Cash ConversionOCF / Net Profit
4.07×
TTM Free Cash FlowTrailing 4 quarters
$242.5M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
UPWK
UPWK
ZLAB
ZLAB
Q4 25
$63.7M
$-26.0M
Q3 25
$75.1M
$-32.0M
Q2 25
$72.5M
$-31.0M
Q1 25
$37.0M
$-61.7M
Q4 24
$38.6M
$-55.8M
Q3 24
$61.0M
$-26.8M
Q2 24
$39.2M
$-42.2M
Q1 24
$14.8M
$-90.1M
Free Cash Flow
UPWK
UPWK
ZLAB
ZLAB
Q4 25
$63.2M
$-26.7M
Q3 25
$74.6M
$-35.0M
Q2 25
$70.1M
$-33.9M
Q1 25
$34.5M
$-63.2M
Q4 24
$37.0M
$-58.4M
Q3 24
$59.8M
$-28.2M
Q2 24
$38.6M
$-42.9M
Q1 24
$14.6M
$-91.1M
FCF Margin
UPWK
UPWK
ZLAB
ZLAB
Q4 25
31.9%
-21.0%
Q3 25
37.0%
-30.4%
Q2 25
36.0%
-31.1%
Q1 25
17.9%
-59.9%
Q4 24
19.3%
-53.8%
Q3 24
30.8%
-27.7%
Q2 24
20.0%
-42.9%
Q1 24
7.7%
-104.5%
Capex Intensity
UPWK
UPWK
ZLAB
ZLAB
Q4 25
0.2%
0.5%
Q3 25
0.2%
2.6%
Q2 25
1.2%
2.6%
Q1 25
1.3%
1.5%
Q4 24
0.8%
2.4%
Q3 24
0.6%
1.3%
Q2 24
0.3%
0.7%
Q1 24
0.1%
1.1%
Cash Conversion
UPWK
UPWK
ZLAB
ZLAB
Q4 25
4.07×
Q3 25
2.56×
Q2 25
2.22×
Q1 25
0.98×
Q4 24
0.26×
Q3 24
2.20×
Q2 24
1.76×
Q1 24
0.80×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

UPWK
UPWK

Segment breakdown not available.

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons